Activated platelet phospholipid surface (APPS)

The activated platelet phospholipid surface is a dynamic procoagulant scaffold that emerges on the outer leaflet of the platelet plasma membrane following activation by agonists such as collagen or thrombin. In resting platelets, negatively charged phospholipids like phosphatidylserine (PS) are actively sequestered in the inner leaflet by flippase enzymes. Upon activation, a rise in cytosolic calcium triggers scramblase activity and inhibits flippases, leading to the rapid externalization of PS (Heemskerk et al., 2002). This anionic surface is essential for the calcium-dependent assembly of the tenase and prothrombinase complexes, which accelerate thrombin production by several orders of magnitude (Zwaal et al., 2005). Pathologically, this surface is a key driver of arterial and venous thrombosis, contributing to myocardial infarction and stroke. Therapeutic strategies targeting this surface, such as Annexin V derivatives, aim to mask the exposed PS to inhibit the coagulation cascade at its site of initiation (Lentz, 2003). This approach represents a novel class of anticoagulants that potentially offer a more localized effect compared to systemic protease inhibitors.

Other names

Procoagulant platelet surfacePhosphatidylserine-exposed membraneAnionic phospholipid surfacePlatelet procoagulant membraneProcoagulant phospholipid surface

The primary mechanism involves the high-affinity binding and masking of externalized anionic phospholipids, specifically phosphatidylserine (PS), on the activated platelet membrane. This steric hindrance prevents the calcium-dependent binding of Vitamin K-dependent clotting factors and their cofactors, effectively halting the assembly of the tenase and prothrombinase complexes and suppressing the explosive generation of thrombin (Lentz, 2003; Zwaal et al., 2005).